Carvedilol Or Metoprolol European Trial - COMET

Description:

The goal of the Carvedilol Or Metoprolol European Trial (COMET) was to evaluate mortality and morbidity between the multiple adrenergic inhibitor carvedilol and the beta-1-selective agent metoprolol among patients with moderate and severe chronic heart failure (CHF).